Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) saw a large drop in short interest in August. As of August 15th, there was short interest totaling 4,126,300 shares, a drop of 19.5% from the July 31st total of 5,126,800 shares. Based on an average daily volume of 5,118,500 shares, the short-interest ratio is presently 0.8 days. Based on an average daily volume of 5,118,500 shares, the short-interest ratio is presently 0.8 days.
Analyst Ratings Changes
Separately, Cormark upgraded Curaleaf from a "hold" rating to a "moderate buy" rating in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the company currently has a consensus rating of "Strong Buy".
Check Out Our Latest Analysis on Curaleaf
Curaleaf Stock Down 6.8%
OTCMKTS:CURLF traded down $0.18 during trading hours on Friday, hitting $2.41. 815,699 shares of the company traded hands, compared to its average volume of 1,143,510. The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00. The firm's 50-day simple moving average is $2.10 and its 200-day simple moving average is $1.31. Curaleaf has a one year low of $0.68 and a one year high of $3.65. The company has a market cap of $1.61 billion, a PE ratio of -7.52 and a beta of 0.75.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%. Equities analysts predict that Curaleaf will post -0.25 earnings per share for the current year.
Curaleaf Company Profile
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Stories
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.